Chronic Respiratory Diseases and Neurodegenerative Disorders: A Primer for the Practicing Clinician

Chronic respiratory disorders represent a world epidemic. Their incidence and prevalence in the world population is increasing, and especially among elderly subjects, they are commonly associated with other pathologies, often generating a status of high clinical complexity. Neurology, internal medic...

Full description

Saved in:
Bibliographic Details
Published inMedical principles and practice Vol. 30; no. 6; pp. 501 - 507
Main Authors Falsetti, Lorenzo, Viticchi, Giovanna, Zaccone, Vincenzo, Tarquinio, Nicola, Nobili, Lorenzo, Nitti, Cinzia, Salvi, Aldo, Moroncini, Gianluca, Silvestrini, Mauro
Format Journal Article
LanguageEnglish
Published Basel, Switzerland S. Karger AG 01.12.2021
Subjects
Aged
Aging
Alzheimer Disease
Alzheimer's disease
Asthma
Chronic obstructive pulmonary disease
Cognitive ability
Dysphagia
Dyspnea
Granulomas
Humans
Hypotheses
Lung cancer
Lung diseases
Neurodegeneration
Neurodegenerative Diseases
Ostomy
Parkinson Disease
Parkinson's disease
Pathology
Pneumonia
Respiratory diseases
Respiratory failure
Respiratory Tract Diseases
Review
Risk factors
Sleep disorders
Smoking
Swallowing
Neurologic diseases
Alzheimer’s disease
Respiratory diseases
Parkinson’s disease
Online AccessGet full text
ISSN1011-7571
1423-0151
1423-0151
DOI10.1159/000518261

Cover

Abstract Chronic respiratory disorders represent a world epidemic. Their incidence and prevalence in the world population is increasing, and especially among elderly subjects, they are commonly associated with other pathologies, often generating a status of high clinical complexity. Neurology, internal medicine, and pneumology specialists should be aware of the common background of these disorders in order to treat correctly the patient’s comorbid state and optimize the treatment considering potential overlaps. In this review, we aimed to focus on the relationships between chronic respiratory disorders and chronic neurodegenerative diseases at different levels; we review the shared risk factors and the interactions between disorders, the indications to explore respiratory function in neurodegenerative diseases, pathology-pathology and drug-pathology interactions in patients affected by both chronic neurologic and respiratory diseases.
AbstractList Chronic respiratory disorders represent a world epidemic. Their incidence and prevalence in the world population is increasing, and especially among elderly subjects, they are commonly associated with other pathologies, often generating a status of high clinical complexity. Neurology, internal medicine, and pneumology specialists should be aware of the common background of these disorders in order to treat correctly the patient's comorbid state and optimize the treatment considering potential overlaps. In this review, we aimed to focus on the relationships between chronic respiratory disorders and chronic neurodegenerative diseases at different levels; we review the shared risk factors and the interactions between disorders, the indications to explore respiratory function in neurodegenerative diseases, pathology-pathology and drug-pathology interactions in patients affected by both chronic neurologic and respiratory diseases.Chronic respiratory disorders represent a world epidemic. Their incidence and prevalence in the world population is increasing, and especially among elderly subjects, they are commonly associated with other pathologies, often generating a status of high clinical complexity. Neurology, internal medicine, and pneumology specialists should be aware of the common background of these disorders in order to treat correctly the patient's comorbid state and optimize the treatment considering potential overlaps. In this review, we aimed to focus on the relationships between chronic respiratory disorders and chronic neurodegenerative diseases at different levels; we review the shared risk factors and the interactions between disorders, the indications to explore respiratory function in neurodegenerative diseases, pathology-pathology and drug-pathology interactions in patients affected by both chronic neurologic and respiratory diseases.
Chronic respiratory disorders represent a world epidemic. Their incidence and prevalence in the world population is increasing, and especially among elderly subjects, they are commonly associated with other pathologies, often generating a status of high clinical complexity. Neurology, internal medicine, and pneumology specialists should be aware of the common background of these disorders in order to treat correctly the patient’s comorbid state and optimize the treatment considering potential overlaps. In this review, we aimed to focus on the relationships between chronic respiratory disorders and chronic neurodegenerative diseases at different levels; we review the shared risk factors and the interactions between disorders, the indications to explore respiratory function in neurodegenerative diseases, pathology-pathology and drug-pathology interactions in patients affected by both chronic neurologic and respiratory diseases.
Author Silvestrini, Mauro
Nitti, Cinzia
Tarquinio, Nicola
Nobili, Lorenzo
Salvi, Aldo
Viticchi, Giovanna
Zaccone, Vincenzo
Moroncini, Gianluca
Falsetti, Lorenzo
AuthorAffiliation d Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy
b Neurological Clinic, Azienda Ospedaliero-Universitaria “Ospedali Riuniti,”, Ancona, Italy
a Internal and Subintensive Medicine Department, Azienda Ospedaliero-Universitaria “Ospedali Riuniti,”, Ancona, Italy
c Internal Medicine Department, INRCA-IRCSS, Osimo (Ancona), Italy
AuthorAffiliation_xml – name: a Internal and Subintensive Medicine Department, Azienda Ospedaliero-Universitaria “Ospedali Riuniti,”, Ancona, Italy
– name: d Department of Clinical and Molecular Sciences, Marche Polytechnic University, Ancona, Italy
– name: c Internal Medicine Department, INRCA-IRCSS, Osimo (Ancona), Italy
– name: b Neurological Clinic, Azienda Ospedaliero-Universitaria “Ospedali Riuniti,”, Ancona, Italy
Author_xml – sequence: 1
  givenname: Lorenzo
  surname: Falsetti
  fullname: Falsetti, Lorenzo
  email: *Lorenzo Falsetti, drfalsetti@yahoo.it
– sequence: 2
  givenname: Giovanna
  surname: Viticchi
  fullname: Viticchi, Giovanna
– sequence: 3
  givenname: Vincenzo
  surname: Zaccone
  fullname: Zaccone, Vincenzo
– sequence: 4
  givenname: Nicola
  surname: Tarquinio
  fullname: Tarquinio, Nicola
– sequence: 5
  givenname: Lorenzo
  surname: Nobili
  fullname: Nobili, Lorenzo
– sequence: 6
  givenname: Cinzia
  surname: Nitti
  fullname: Nitti, Cinzia
– sequence: 7
  givenname: Aldo
  surname: Salvi
  fullname: Salvi, Aldo
– sequence: 8
  givenname: Gianluca
  surname: Moroncini
  fullname: Moroncini, Gianluca
– sequence: 9
  givenname: Mauro
  surname: Silvestrini
  fullname: Silvestrini, Mauro
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34348307$$D View this record in MEDLINE/PubMed
BookMark eNptkctr3DAQh0VJaV499F6KoZf24EZjWbaUQyFsn5DHUtqzkKXxrlKvtJXsQP77atnN0oacJDHffPw0c0wOfPBIyCugHwC4PKOUchBVA8_IEdQVKylwOMh3ClC2vIVDcpzSbcYEY_QFOWQ1qwWj7RExs2UM3pniB6a1i3oM8b745BLqhKnQ3hbXOMVgcYEec9nd4aYcosWYzouLYh7dCmPRh1iMS8xPbUZnnF8Us8FlsdP-lDzv9ZDw5e48Ib--fP45-1Ze3nz9Pru4LA0HOZa9EGhAQsdZJaTujK20ZV0DnTXGUmgZF1zX3HS1bXjXYy21BClb06DVtmMn5OPWu566FVqDfox6UOucUMd7FbRT_1e8W6pFuFOirSnQJgve7QQx_JkwjWrlksFh0B7DlFTFuah500qW0beP0NswRZ-_pypJKQMhW5qpN_8m2kd5mH8GzraAiSGliL0ybsxTDpuAblBA1WbDar_h3PH-UceD9Cl2F_K3jguMe_JqPt8Sam37TL1-ktpJ_gJo77tp
CitedBy_id crossref_primary_10_3928_23258160_20240220_01
crossref_primary_10_3390_sports13010009
crossref_primary_10_1016_j_lfs_2024_122909
crossref_primary_10_1111_ene_15743
crossref_primary_10_3390_biomedicines10020439
Cites_doi 10.1097/00002826-200603000-00005
10.1016/j.parkreldis.2010.07.004
10.1161/01.STR.0000226403.00963.af
10.1016/0022-510x(96)00003-2
10.1378/chest.07-1446
10.1111/j.1469-7793.2001.t01-1-00237.x
10.1056/NEJM198412063112314
10.4049/jimmunol.1002449
10.1016/s0025-7125(02)00007-x
10.1111/j.1468-1331.2010.03340.x
10.1136/jnnp.51.1.161
10.1016/s1579-2129(07)60118-9
10.1001/archinte.1982.00340210062015
10.1212/WNL.0000000000000879
10.1155/2014/103780
10.1016/j.ejim.2004.09.014
10.1001/jama.285.22.2888
10.1159/000356498
10.1002/mds.10072
10.1097/JTO.0000000000000345
10.1111/jgs.13054
10.1111/j.1582-4934.2008.00296.x
10.1371/journal.pone.0100828
10.1016/j.mehy.2005.06.014
10.1136/jnnp.60.6.615
10.1002/mds.23139
10.1017/s0317167100003991
10.1159/000029224
10.2174/1567205011310050011
10.1001/archinternmed.2009.229
10.1016/j.parkreldis.2007.12.007
10.1513/AnnalsATS.201310-360OC
10.1093/sleep/23.3.1c
10.1158/1055-9965.EPI-07-0038
10.1016/s0140-6736(00)02824-5
10.2147/ndt.s2006
10.1016/j.neurobiolaging.2011.09.038
10.1055/s-2002-33034
10.1001/jamainternmed.2014.7663
10.1002/mds.21730
10.3233/JAD-170445
10.1016/j.rmed.2012.03.013
10.1007/978-3-540-69248-5_6
10.3390/ijerph7103760
10.1164/ajrccm/148.2.418
10.1378/chest.130.6.1687
10.1007/s00455-009-9244-x
10.1002/mds.21992
10.1016/S1474-4422(11)70072-2
10.1016/s0197-4580(02)00156-2
10.1007/978-3-540-69248-5_5
10.1016/s0003-9993(96)90216-6
10.1016/j.jns.2006.03.008
10.1001/archneur.62.8.1290
10.1097/01.pas.0000213418.08009.f9
10.1164/rccm.200902-0276OC
10.1021/acschemneuro.8b00442
10.1345/aph.1C036
10.1007/s00702-005-0348-7
10.7150/thno.21408
10.1016/s0954-6111(03)00188-4
10.1093/ageing/afj087
10.1378/chest.11-3035
10.1002/ana.10277
10.1097/00005768-199906000-00001
ContentType Journal Article
Copyright 2021 The Author(s). Published by S. Karger AG, Basel
2021 The Author(s). Published by S. Karger AG, Basel.
2021 The Author(s). Published by S. Karger AG, Basel . This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright © 2021 by S. Karger AG, Basel 2021
Copyright_xml – notice: 2021 The Author(s). Published by S. Karger AG, Basel
– notice: 2021 The Author(s). Published by S. Karger AG, Basel.
– notice: 2021 The Author(s). Published by S. Karger AG, Basel . This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright © 2021 by S. Karger AG, Basel 2021
DBID M--
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOI 10.1159/000518261
DatabaseName Karger Open Access Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef

ProQuest One Academic Middle East (New)

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: M--
  name: Karger Open Access Journals
  url: https://www.karger.com/OpenAccess
  sourceTypes:
    Enrichment Source
    Publisher
– sequence: 4
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1423-0151
EndPage 507
ExternalDocumentID PMC8740106
34348307
10_1159_000518261
518261
Genre Journal Article
Review
GroupedDBID ---
0R~
0~B
30W
326
36B
3O.
3V.
4.4
53G
5GY
7X7
88E
8FI
8FJ
8UI
AAWTL
AAYIC
ABPAZ
ABUWG
ACGFS
ADBBV
AENEX
AEYAO
AFKRA
AHMBA
ALDHI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZPMC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
CS3
CYUIP
DIK
DU5
E0A
E3Z
EBS
EMB
EMOBN
F5P
FB.
FYUFA
GROUPED_DOAJ
HMCUK
HYE
HZ~
IAO
IHR
KUZGX
M--
M1P
MK0
O1H
O9-
OK1
P2P
PQQKQ
PROAC
PSQYO
RKO
RNS
RPM
SV3
UJ6
UKHRP
AAYXX
ABBTS
ABWCG
ACQXL
ADAGL
AFJJK
AFSIO
AHFRZ
AIOBO
CAG
CITATION
COF
EJD
ITC
PHGZM
PHGZT
PJZUB
PPXIY
RXVBD
TR2
CGR
CUY
CVF
ECM
EIF
NPM
RIG
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
7X8
5PM
ID FETCH-LOGICAL-c519t-f88ec191b53289abcd2ad3b61bdccd0173585a45cb4d65bfe49a91997c6edadb3
IEDL.DBID M--
ISSN 1011-7571
1423-0151
IngestDate Thu Aug 21 14:11:17 EDT 2025
Tue Aug 05 11:00:40 EDT 2025
Fri Jul 25 23:45:49 EDT 2025
Mon Jul 21 06:05:12 EDT 2025
Wed Aug 20 07:45:03 EDT 2025
Thu Apr 24 22:59:51 EDT 2025
Thu Aug 29 12:04:32 EDT 2024
Thu Sep 05 17:57:58 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Neurologic diseases
Alzheimer’s disease
Respiratory diseases
Parkinson’s disease
Language English
License This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission.
https://creativecommons.org/licenses/by-nc/4.0
2021 The Author(s). Published by S. Karger AG, Basel.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c519t-f88ec191b53289abcd2ad3b61bdccd0173585a45cb4d65bfe49a91997c6edadb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
OpenAccessLink https://karger.com/doi/10.1159/000518261
PMID 34348307
PQID 2900318970
PQPubID 2047984
PageCount 7
ParticipantIDs crossref_citationtrail_10_1159_000518261
proquest_miscellaneous_2558456793
karger_primary_518261
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8740106
crossref_primary_10_1159_000518261
proquest_journals_2900318970
pubmed_primary_34348307
PublicationCentury 2000
PublicationDate 2021-12-01
PublicationDateYYYYMMDD 2021-12-01
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-01
  day: 01
PublicationDecade 2020
PublicationPlace Basel, Switzerland
PublicationPlace_xml – name: Basel, Switzerland
– name: Switzerland
– name: Basel
– name: Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH–4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.com
PublicationTitle Medical principles and practice
PublicationTitleAlternate Med Princ Pract
PublicationYear 2021
Publisher S. Karger AG
Publisher_xml – name: S. Karger AG
References Nóbrega AC, Rodrigues B, Melo A. Is silent aspiration a risk factor for respiratory infection in Parkinson’s disease patients. Parkinsonism Relat Disord. 2008 Dec;14:646–8.
Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol. 2011 Sep;10:819–28.
Valko PO, Hauser S, Sommerauer M, Werth E, Baumann CR. Observations on sleep-disordered breathing in idiopathic Parkinson’s disease. PLoS One. 2014 Jun;9:e100828.
Abrams B. Add Alzheimer’s to the list of sleep apnea consequences. Med Hypotheses. 2005 Jan;65:1201–2.
Shill H, Stacy M. Respiratory complications of Parkinson’s disease. Semin Respir Crit Care Med. 2002;23:261–5.
Ott A, Slooter AJ, Hofman A, van Harskamp F, Witteman JC, Van Broeckhoven C, . Smoking and risk of dementia and Alzheimer’s disease in a population-based cohort study: the Rotterdam Study. Lancet. 1998 Jun [cited 2015 Dec 4];351:1840–3.
Sabaté M, Rodríguez M, Méndez E, Enríquez E, González I. Obstructive and restrictive pulmonary dysfunction increases disability in Parkinson disease. Arch Phys Med Rehabil. 1996;77:29–34.
Iturriaga R, Alcayaga J, Gonzalez C. Neurotransmitters in carotid body function: the case of dopamine. Adv Exp Med Biol. 2009;648:137–43.
Villeneuve S, Pepin V, Rahayel S, Bertrand JA, de Lorimier M, Rizk A, . Mild cognitive impairment in moderate to severe COPD. Chest. 2012 Dec;142(6):1516.
Driver JA, Logroscino G, Buring JE, Gaziano JM, Kurth T. A prospective cohort study of cancer incidence following the diagnosis of Parkinson’s disease. Cancer Epidemiol Biomarkers Prev. 2007 Jun;16:1260–5.
Carrière I, Fourrier-Reglat A, Dartigues JF, Rouaud O, Pasquier F, Ritchie K, . Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med. 2009 Jul;169:1317–24.
Schou L, Østergaard B, Rasmussen LS, Rydahl-Hansen S, Phanareth K. Cognitive dysfunction in patients with chronic obstructive pulmonary disease: a systematic review. Respir Med. 2012 Aug;106:1071–81.
Kalf JG, de Swart BJM, Bloem BR, Munneke M. Prevalence of oropharyngeal dysphagia in Parkinson’s disease: a meta-analysis. Park Relat Disord. 2012 May;18:311–5.
Wetter TC, Collado-Seidel V, Pollmächer T, Yassouridis A, Trenkwalder C. Sleep and periodic leg movement patterns in drug-free patients with Parkinson’s disease and multiple system atrophy. Sleep. 2000 May;23:361–7.
Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, . The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson’s disease. Mov Disord. 2011 Oct;26 Suppl 3:S42–80.
Cooke JR, Ayalon L, Palmer BW, Loredo JS, Corey-Bloom J, Natarajan L, . Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer’s disease and obstructive sleep apnea: a preliminary study. J Clin Sleep Med. 2009 Aug [cited 2015 Nov 20];5:305–9.
Kadotani H, Kadotani T, Young T, Peppard PE, Finn L, Colrain IM, . Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults. JAMA. 2001 Jun [cited 2015 Dec 4];285:2888–90.
Taylor AM, Hoehns JD, Anderson DM, Tobert DG, Morand BR, Demers D. Fatal aspiration pneumonia during transition from donepezil to rivastigmine. Ann Pharmacother. 2002 Oct;36:1550–3.
Dhawan V, Healy DG, Pal S, Chaudhuri KR. Sleep-related problems of Parkinson’s disease. Age Ageing. 2006 May;35:220–8.
Tyas SL, White LR, Petrovitch H, Webster Ross G, Foley DJ, Heimovitz HK, . Mid-life smoking and late-life dementia: the Honolulu-Asia aging study. Neurobiol Aging. 2003 Jul–Aug [cited 2015 Dec 4];24:589–96.
Bonner LT, Peskind ER. Pharmacologic treatments of dementia. Med Clin North Am. 2002 May [cited 2015 Dec 4];86:657–74.
Ancoli-Israel S, Palmer BW, Cooke JR, Corey-Bloom J, Fiorentino L, Natarajan L, . Cognitive effects of treating obstructive sleep apnea in Alzheimer’s disease: a randomized controlled study. J Am Geriatr Soc. 2008 Nov;56:2076–81.
Goldacre M. Differential risks of cancer types in people with Parkinson’s disease: a national record-linkage study. Eur J Cancer. 2014 Sep;50:2456–62.
Inzelberg R, Peleg N, Nisipeanu P, Magadle R, Carasso RL, Weiner P. Inspiratory muscle training and the perception of dyspnea in Parkinson’s disease. Can J Neurol Sci. 2005;32:213–7.
Durazzo TC, Mattsson N, Weiner MW. Smoking and increased Alzheimer’s disease risk: a review of potential mechanisms. Alzheimers Dement. 2014 Jun;10(3 Suppl l):S122–45.
Hartman DE. Stridor during dystonia phases of Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1988;51:161.
Sánchez-Valle J, Tejero H, Ibáñez K, Portero JL, Krallinger M, Al-Shahrour F, . A molecular hypothesis to explain direct and inverse co-morbidities between Alzheimer’s disease, glioblastoma and lung cancer. Sci Rep. 2017;7:4474.
Isono S, Shiba K, Yamaguchi M, Tanaka A, Hattori T, Konno A, . Pathogenesis of laryngeal narrowing in patients with multiple system atrophy. J Physiol. 2001 Oct;536:237–49.
Diederich NJ, Vaillant M, Leischen M, Mancuso G, Golinval S, Nati R, . Sleep apnea syndrome in Parkinson’s disease. A case-control study in 49 patients. Mov Disord. 2005;20:1413–8.
Mehanna R, Jankovic J. Respiratory problems in neurologic movement disorders. Parkinsonism Relat Disord. 2010 Dec;16:628–38.
Kato B, Yamada K, Horiuchi M, Hirayama T, Hasegawa Y. [Case of Parkinson’s disease presenting with unique dyspneic attacks caused by oromandibular dystonia and sleep apnea syndrome]. Rinsho Shinkeigaku. 2007 Sep [cited 2020 Oct 6];47:577–80. Japanese.
Mukhopadhyay S, Katzenstein AL. Pulmonary disease due to aspiration of food and other particulate matter: a clinicopathologic study of 59 cases diagnosed on biopsy or resection specimens. Am J Surg Pathol. 2007 May;31:752–9.
Pathan SS, Gottesman RF, Mosley TH, Knopman DS, Sharrett AR, Alonso A. Association of lung function with cognitive decline and dementia: the atherosclerosis risk in communities (ARIC) study. Eur J Neurol. 2011 Jun;18:888–98.
Guptha SH, Promnitz AD. Pleural effusion and thickening due to cabergoline use in a patient with Parkinson’s disease. Eur J Intern Med. 2005;16:129–31.
Tintner R, Manian P, Gauthier P, Jankovic J. Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson disease. Arch Neurol. 2005 Aug;62:1290–5.
Hung WW, Wisnivesky JP, Siu AL, Ross JS. Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180:134–7.
Buratti L, Viticchi G, Baldinelli S, Falsetti L, Luzzi S, Pulcini A, . Sleep apnea, cognitive profile, and vascular changes: an intriguing relationship. J Alzheimers Dis. 2017;60:1195.
Villavicencio C, Ramírez-Sarmiento A, Gayete A, Grau S, Orozco-Levi M. [Early pleuropulmonary toxicity associated with cabergoline, an antiparkinsonian drug]. Arch Bronconeumol. 2007 Jan;43:519–22. Spanish. http://dx.doi.org/10.1016/s1579-2129(07)60118-9.
Kivipelto M, Rovio S, Ngandu T, Kåreholt I, Eskelinen M, Winblad B, . Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study. J Cell Mol Med. 2008 Dec;12:2762–71.
Kiyohara C, Kusuhara S. Cigarette smoking and Parkinson’s disease: a meta-analysis. Fukuoka Igaku Zasshi. 2011 Aug;102(8):254–65.
Guo X, Waern M, Sjögren K, Lissner L, Bengtsson C, Björkelund C, . Midlife respiratory function and incidence of Alzheimer’s disease: a 29-year longitudinal study in women. Neurobiol Aging. 2007 Mar;28:343–50.
Belmonte Y, de Fabregues O, Marti M, Domingo C. Pleuropulmonary toxicity of another anti-Parkinson’s drug: cabergoline. Open Respir Med J. 2009 Jun;3:90–3.
Hernán MA, Takkouche B, Caamaño-Isorna F, Gestal-Otero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson’s disease. Ann Neurol. 2002 Sep;52:276–84.
Guo X, Pantoni L, Simoni M, Gustafson D, Bengtsson C, Palmertz B, . Midlife respiratory function related to white matter lesions and lacunar infarcts in late life: the prospective population study of women in Gothenburg, Sweden. Stroke. 2006 Jul;37:1658–62.
Ghorayeb I, Bioulac B, Tison F. Sleep disorders in multiple system atrophy. J Neural Transm. 2005;112:1669–75.
Chaudhuri KR, Healy DG, Schapira AHV. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol. 2006 Mar;5:235–45.
Iranzo A, Santamaria J, Tolosa E. Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy. Barcelona Multiple System Atrophy Study Group. Lancet. 2000 Oct;356:1329–30.
Ancelin ML, Carrière I, Helmer C, Rouaud O, Pasquier F, Berr C, . Steroid and nonsteroidal anti-inflammatory drugs, cognitive decline, and dementia. Neurobiol Aging. 2012 Sep;33:2082–90.
Thomsen TR, Galpern WR, Asante A, Arenovich T, Fox SH. Ipratropium bromide spray as treatment for sialorrhea in Parkinson’s disease. Mov Disord. 2007 Nov;22:2268–73.
Ritz B, Lee PC, Lassen CF, Arah OA. Parkinson disease and smoking revisited: ease of quitting is an early sign of the disease. Neurology. 2014 Oct;83:1396–402.
Jankovic J. Camptocormia, head drop and other bent spine syndromes: heterogeneous etiology and pathogenesis of parkinsonian deformities. Mov Disord. 2010 Apr;25:527–8.
Sharma A, Brody AL. In vivo brain imaging of human exposure to nicotine and tobacco. Handb Exp Pharmacol. 2009 Jan;(192):145–71.
Qian L, Wu HM, Chen SH, Zhang D, Ali SF, Peterson L, . β2-Adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway. J Immunol. 2011 Apr;186(7):4443–54.
Peterson L, Ismond KP, Chapman E, Flood P. Potential benefits of therapeutic use of β2-adrenergic receptor agonists in neuroprotection and Parkinsonμs disease. J Immunol Res. 2014;2014:103780.
Arnulf I, Konofal E, Merino-Andreu M, Houeto JL, Mesnage V, Welter ML, . Parkinson’s disease and sleepiness: an integral part of PD. Neurology. 2002 Apr;58:1019–24.
Vázquez A, Jiménez-Jiménez FJ, García-Ruiz P, García-Urra D. “Panic attacks” in Parkinso
ref13
ref57
ref12
ref56
ref15
ref59
ref14
ref58
ref53
ref52
ref11
ref55
ref10
ref54
ref17
ref16
ref19
ref18
ref51
ref50
ref46
ref45
ref48
ref47
ref42
ref41
ref44
ref43
ref49
ref8
ref7
ref9
ref4
ref3
ref6
ref5
ref40
ref35
ref34
ref37
ref36
ref31
ref30
ref33
ref32
ref2
ref1
ref39
ref38
ref24
ref23
ref26
ref25
ref20
ref64
ref63
ref22
ref21
ref65
ref28
ref27
ref29
ref60
ref62
ref61
References_xml – reference: Jankovic J, Aguilar LG. Current approaches to the treatment of Parkinson’s disease. Neuropsychiatr Dis Treat. 2008;4:743–57.
– reference: Kivipelto M, Rovio S, Ngandu T, Kåreholt I, Eskelinen M, Winblad B, . Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study. J Cell Mol Med. 2008 Dec;12:2762–71.
– reference: Driver JA, Logroscino G, Buring JE, Gaziano JM, Kurth T. A prospective cohort study of cancer incidence following the diagnosis of Parkinson’s disease. Cancer Epidemiol Biomarkers Prev. 2007 Jun;16:1260–5.
– reference: Pathan SS, Gottesman RF, Mosley TH, Knopman DS, Sharrett AR, Alonso A. Association of lung function with cognitive decline and dementia: the atherosclerosis risk in communities (ARIC) study. Eur J Neurol. 2011 Jun;18:888–98.
– reference: Ott A, Slooter AJ, Hofman A, van Harskamp F, Witteman JC, Van Broeckhoven C, . Smoking and risk of dementia and Alzheimer’s disease in a population-based cohort study: the Rotterdam Study. Lancet. 1998 Jun [cited 2015 Dec 4];351:1840–3.
– reference: Maria B, Sophia S, Michalis M, Charalampos L, Andreas P, John ME, . Sleep breathing disorders in patients with idiopathic Parkinson’s disease. Respir Med. 2003 Oct;97:1151–7.
– reference: Durazzo TC, Meyerhoff DJ, Nixon SJ. Chronic cigarette smoking: implications for neurocognition and brain neurobiology. Int J Environ Res Public Health. 2010 Oct;7:3760–91.
– reference: Bajaj A, Driver JA, Schernhammer ES. Parkinson’s disease and cancer risk: a systematic review and meta-analysis. Cancer Causes Control. 2010 May;21:697–707.
– reference: Ghorayeb I, Bioulac B, Tison F. Sleep disorders in multiple system atrophy. J Neural Transm. 2005;112:1669–75.
– reference: Sabaté M, Rodríguez M, Méndez E, Enríquez E, González I. Obstructive and restrictive pulmonary dysfunction increases disability in Parkinson disease. Arch Phys Med Rehabil. 1996;77:29–34.
– reference: Kalisch Ellett LM, Pratt NL, Ramsay EN, Barratt JD, Roughead EE. Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia. J Am Geriatr Soc. 2014 Oct;62:1916–22.
– reference: Rice JE, Antic R, Thompson PD. Disordered respiration as a levodopa-induced dyskinesia in Parkinson’s disease. Mov Disord. 2002 May;17:524–7.
– reference: Guptha SH, Promnitz AD. Pleural effusion and thickening due to cabergoline use in a patient with Parkinson’s disease. Eur J Intern Med. 2005;16:129–31.
– reference: Zhang F, Niu L, Li S, Le W. Pathological impacts of chronic hypoxia on Alzheimer’s disease. ACS Chem Neurosci. 2019 Feb;10:902–9.
– reference: Vázquez A, Jiménez-Jiménez FJ, García-Ruiz P, García-Urra D. “Panic attacks” in Parkinson’s disease: a long-term complication of levodopatherapy. Acta Neurol Scand. 1993 Jan;87:14–8.
– reference: Hofmann C, Penner U, Dorow R, Pertz HH, Jähnichen S, Horowski R, . Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis. Clin Neuropharmacol. 2006 Mar;29:80–6.
– reference: Park MH, Yun HM, Hwang CJ, Park SI, Han SB, Hwang DY, . Presenilin mutation suppresses lung tumorigenesis via inhibition of peroxiredoxin 6 activity and expression. Theranostics. 2017;7:3624.
– reference: Kadotani H, Kadotani T, Young T, Peppard PE, Finn L, Colrain IM, . Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults. JAMA. 2001 Jun [cited 2015 Dec 4];285:2888–90.
– reference: Carrière I, Fourrier-Reglat A, Dartigues JF, Rouaud O, Pasquier F, Ritchie K, . Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med. 2009 Jul;169:1317–24.
– reference: Belmonte Y, de Fabregues O, Marti M, Domingo C. Pleuropulmonary toxicity of another anti-Parkinson’s drug: cabergoline. Open Respir Med J. 2009 Jun;3:90–3.
– reference: Jankovic J. Camptocormia, head drop and other bent spine syndromes: heterogeneous etiology and pathogenesis of parkinsonian deformities. Mov Disord. 2010 Apr;25:527–8.
– reference: Stanley RK, Protas EJ, Jankovic J. Exercise performance in those having Parkinson’s disease and healthy normals. Med Sci Sports Exerc. 1999;31:761–6.
– reference: Ancoli-Israel S, Palmer BW, Cooke JR, Corey-Bloom J, Fiorentino L, Natarajan L, . Cognitive effects of treating obstructive sleep apnea in Alzheimer’s disease: a randomized controlled study. J Am Geriatr Soc. 2008 Nov;56:2076–81.
– reference: Incalzi RA, Gemma A, Marra C, Muzzolon R, Capparella O, Carbonin P. Chronic obstructive pulmonary disease. An original model of cognitive decline. Am Rev Respir Dis. 1993 Aug;148:418–24.
– reference: Cooke JR, Ayalon L, Palmer BW, Loredo JS, Corey-Bloom J, Natarajan L, . Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer’s disease and obstructive sleep apnea: a preliminary study. J Clin Sleep Med. 2009 Aug [cited 2015 Nov 20];5:305–9.
– reference: Kalf JG, de Swart BJM, Bloem BR, Munneke M. Prevalence of oropharyngeal dysphagia in Parkinson’s disease: a meta-analysis. Park Relat Disord. 2012 May;18:311–5.
– reference: Iturriaga R, Alcayaga J, Gonzalez C. Neurotransmitters in carotid body function: the case of dopamine. Adv Exp Med Biol. 2009;648:137–43.
– reference: Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol. 2011 Sep;10:819–28.
– reference: Ritz B, Lee PC, Lassen CF, Arah OA. Parkinson disease and smoking revisited: ease of quitting is an early sign of the disease. Neurology. 2014 Oct;83:1396–402.
– reference: Mehanna R, Jankovic J. Respiratory problems in neurologic movement disorders. Parkinsonism Relat Disord. 2010 Dec;16:628–38.
– reference: Hernán MA, Takkouche B, Caamaño-Isorna F, Gestal-Otero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson’s disease. Ann Neurol. 2002 Sep;52:276–84.
– reference: Iranzo A, Santamaria J, Tolosa E. Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy. Barcelona Multiple System Atrophy Study Group. Lancet. 2000 Oct;356:1329–30.
– reference: Serebrovskaya T, Karaban I, Mankovskaya I, Bernardi L, Passino C, Appenzeller O. Hypoxic ventilatory responses and gas exchange in patients with Parkinson’s disease. Respiration. 1998 Jan;65:28–33.
– reference: Valko PO, Hauser S, Sommerauer M, Werth E, Baumann CR. Observations on sleep-disordered breathing in idiopathic Parkinson’s disease. PLoS One. 2014 Jun;9:e100828.
– reference: Nonaka M, Imai T, Shintani T, Kawamata M, Chiba S, Matsumoto H. Non-invasive positive pressure ventilation for laryngeal contraction disorder during sleep in multiple system atrophy. J Neurol Sci. 2006 Aug;247:53–8.
– reference: Tintner R, Manian P, Gauthier P, Jankovic J. Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson disease. Arch Neurol. 2005 Aug;62:1290–5.
– reference: Antonelli-Incalzi R, Corsonello A, Pedone C, Trojano L, Acanfora D, Spada A, . Drawing impairment predicts mortality in severe COPD. Chest. 2006 Dec;130:1687–94.
– reference: Azizian A, Monterosso J, O’Neill J, London ED. Magnetic resonance imaging studies of cigarette smoking. Handb Exp Pharmacol. 2009 Jan;(192):113–43.
– reference: Peterson L, Ismond KP, Chapman E, Flood P. Potential benefits of therapeutic use of β2-adrenergic receptor agonists in neuroprotection and Parkinsonμs disease. J Immunol Res. 2014;2014:103780.
– reference: Regan J, Walshe M, Tobin WO. Immediate effects of thermal-tactile stimulation on timing of swallow in idiopathic Parkinson’s disease. Dysphagia. 2010 Sep;25:207–15.
– reference: Chaudhuri KR, Healy DG, Schapira AHV. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol. 2006 Mar;5:235–45.
– reference: Isono S, Shiba K, Yamaguchi M, Tanaka A, Hattori T, Konno A, . Pathogenesis of laryngeal narrowing in patients with multiple system atrophy. J Physiol. 2001 Oct;536:237–49.
– reference: Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, . The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson’s disease. Mov Disord. 2011 Oct;26 Suppl 3:S42–80.
– reference: Inzelberg R, Peleg N, Nisipeanu P, Magadle R, Carasso RL, Weiner P. Inspiratory muscle training and the perception of dyspnea in Parkinson’s disease. Can J Neurol Sci. 2005;32:213–7.
– reference: Dhawan V, Healy DG, Pal S, Chaudhuri KR. Sleep-related problems of Parkinson’s disease. Age Ageing. 2006 May;35:220–8.
– reference: Durazzo TC, Mattsson N, Weiner MW. Smoking and increased Alzheimer’s disease risk: a review of potential mechanisms. Alzheimers Dement. 2014 Jun;10(3 Suppl l):S122–45.
– reference: Abrams B. Add Alzheimer’s to the list of sleep apnea consequences. Med Hypotheses. 2005 Jan;65:1201–2.
– reference: Ou SM, Lee YJ, Hu YW, Liu CJ, Chen TJ, Fuh JL, . Does Alzheimer’s disease protect against cancers? A nationwide population-based study. Neuroepidemiology. 2012 Dec;40:42–9.
– reference: Buratti L, Viticchi G, Baldinelli S, Falsetti L, Luzzi S, Pulcini A, . Sleep apnea, cognitive profile, and vascular changes: an intriguing relationship. J Alzheimers Dis. 2017;60:1195.
– reference: Hung WW, Wisnivesky JP, Siu AL, Ross JS. Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;180:134–7.
– reference: Estenne M, Hubert M, de Troyer A, Vincken WG, Gauthier SG, Dollfuss RE, . Respiratory-muscle involvement in Parkinson’s disease. N Engl J Med. 1984 Dec;311(23):1516–7.
– reference: Simó M, Root JC, Vaquero L, Ripollés P, Jové J, Ahles T, . Cognitive and brain structural changes in a lung cancer population. J Thorac Oncol. 2015 Jan;10:38–45.
– reference: Cardasis JJ, MacMahon H, Husain AN. The spectrum of lung disease due to chronic occult aspiration. Ann Am Thorac Soc. 2014 Jul;11:865–73.
– reference: Guo X, Pantoni L, Simoni M, Gustafson D, Bengtsson C, Palmertz B, . Midlife respiratory function related to white matter lesions and lacunar infarcts in late life: the prospective population study of women in Gothenburg, Sweden. Stroke. 2006 Jul;37:1658–62.
– reference: Bonner LT, Peskind ER. Pharmacologic treatments of dementia. Med Clin North Am. 2002 May [cited 2015 Dec 4];86:657–74.
– reference: Villavicencio C, Ramírez-Sarmiento A, Gayete A, Grau S, Orozco-Levi M. [Early pleuropulmonary toxicity associated with cabergoline, an antiparkinsonian drug]. Arch Bronconeumol. 2007 Jan;43:519–22. Spanish. http://dx.doi.org/10.1016/s1579-2129(07)60118-9.
– reference: Sabaté M, González I, Ruperez F, Rodríguez M. Obstructive and restrictive pulmonary dysfunctions in Parkinson’s disease. J Neurol Sci. 1996;138:114–9.
– reference: Grant I, Heaton RK, McSweeny AJ, Adams KM, Timms RM. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med. 1982 Aug [cited 2015 Dec 4];142:1470–6.
– reference: Sathyaprabha TN, Kapavarapu PK, Pall PK, Thennarasu K, Raju TR. Pulmonary functions in Parkinson’s disease. Indian J Chest Dis Allied Sci. 2005 [cited 2020 Oct 6];47(4):251–7. Available from: https://www.researchgate.net/publication/7512303.
– reference: Rusanen M, Rovio S, Ngandu T, Nissinen A, Tuomilehto J, Soininen H, . Midlife smoking, apolipoprotein E and risk of dementia and Alzheimer’s disease: a population-based cardiovascular risk factors, aging and dementia study. Dement Geriatr Cogn Disord. 2010 Jan;30:277–84.
– reference: Li CH, Chen WC, Liao WC, Tu CY, Lin CL, Sung FC, . The association between chronic obstructive pulmonary disease and Parkinson’s disease: a nationwide population-based retrospective cohort study. QJM. 2015 Jan;108:39–45.
– reference: Taylor AM, Hoehns JD, Anderson DM, Tobert DG, Morand BR, Demers D. Fatal aspiration pneumonia during transition from donepezil to rivastigmine. Ann Pharmacother. 2002 Oct;36:1550–3.
– reference: Sharma A, Brody AL. In vivo brain imaging of human exposure to nicotine and tobacco. Handb Exp Pharmacol. 2009 Jan;(192):145–71.
– reference: Qian L, Wu HM, Chen SH, Zhang D, Ali SF, Peterson L, . β2-Adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway. J Immunol. 2011 Apr;186(7):4443–54.
– reference: Sánchez-Valle J, Tejero H, Ibáñez K, Portero JL, Krallinger M, Al-Shahrour F, . A molecular hypothesis to explain direct and inverse co-morbidities between Alzheimer’s disease, glioblastoma and lung cancer. Sci Rep. 2017;7:4474.
– reference: Hartman DE. Stridor during dystonia phases of Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1988;51:161.
– reference: Onoue H, Yukitake M, Kurohara K, Takasima H, Kuroda Y. [A case report of Parkinson’s disease presenting with recurrent dyspneic attacks due to focal laryngeal dystonia]. Rinsho Shinkeigaku. 2003 Apr [cited 2020 Oct 6];43:192–4. Japanese.
– reference: Schou L, Østergaard B, Rasmussen LS, Rydahl-Hansen S, Phanareth K. Cognitive dysfunction in patients with chronic obstructive pulmonary disease: a systematic review. Respir Med. 2012 Aug;106:1071–81.
– reference: Rusanen M, Ngandu T, Laatikainen T, Tuomilehto J, Soininen H, Kivipelto M. Chronic obstructive pulmonary disease and asthma and the risk of mild cognitive impairment and dementia: a population based CAIDE study. Curr Alzheimer Res. 2013 Jun [cited 2015 Dec 4];10:549–55.
– reference: Saleem AF, Sapienza CM, Okun MS. Respiratory muscle strength training: treatment and response duration in a patient with early idiopathic Parkinson’s disease. NeuroRehabilitation. 2005 Jan;20:323–33.
– reference: Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, . Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015 Mar;175:401–7.
– reference: Mukhopadhyay S, Katzenstein AL. Pulmonary disease due to aspiration of food and other particulate matter: a clinicopathologic study of 59 cases diagnosed on biopsy or resection specimens. Am J Surg Pathol. 2007 May;31:752–9.
– reference: Köllensperger M, Geser F, Seppi K, Stampfer-Kountchev M, Sawires M, Scherfler C, . Red flags for multiple system atrophy. Mov Disord. 2008 Jun;23:1093–9.
– reference: Shill H, Stacy M. Respiratory complications of Parkinson’s disease. Semin Respir Crit Care Med. 2002;23:261–5.
– reference: Ancelin ML, Carrière I, Helmer C, Rouaud O, Pasquier F, Berr C, . Steroid and nonsteroidal anti-inflammatory drugs, cognitive decline, and dementia. Neurobiol Aging. 2012 Sep;33:2082–90.
– reference: Tyas SL, White LR, Petrovitch H, Webster Ross G, Foley DJ, Heimovitz HK, . Mid-life smoking and late-life dementia: the Honolulu-Asia aging study. Neurobiol Aging. 2003 Jul–Aug [cited 2015 Dec 4];24:589–96.
– reference: Villeneuve S, Pepin V, Rahayel S, Bertrand JA, de Lorimier M, Rizk A, . Mild cognitive impairment in moderate to severe COPD. Chest. 2012 Dec;142(6):1516.
– reference: Buratti L, Viticchi G, Falsetti L, Cagnetti C, Luzzi S, Bartolini M, . Vascular impairment in Alzheimer’s disease: the role of obstructive sleep apnea. J Alzheimers Dis. 2014 Jan;38:445–53.
– reference: GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014 Dec;385:117–71.
– reference: Guo X, Waern M, Sjögren K, Lissner L, Bengtsson C, Björkelund C, . Midlife respiratory function and incidence of Alzheimer’s disease: a 29-year longitudinal study in women. Neurobiol Aging. 2007 Mar;28:343–50.
– reference: Kiyohara C, Kusuhara S. Cigarette smoking and Parkinson’s disease: a meta-analysis. Fukuoka Igaku Zasshi. 2011 Aug;102(8):254–65.
– reference: Wetter TC, Collado-Seidel V, Pollmächer T, Yassouridis A, Trenkwalder C. Sleep and periodic leg movement patterns in drug-free patients with Parkinson’s disease and multiple system atrophy. Sleep. 2000 May;23:361–7.
– reference: Goldacre M. Differential risks of cancer types in people with Parkinson’s disease: a national record-linkage study. Eur J Cancer. 2014 Sep;50:2456–62.
– reference: Greco A, Valle JS, Pancaldi V, Baudot A, Barillot E, Caselle M, . Molecular inverse comorbidity between Alzheimer’s disease and lung cancer: new insights from matrix factorization. Int J Mol Sci. 2019 Jul;20(13):3114.
– reference: Litvan I, Mangone CA, McKee A, Verny M, Parsa A, Jellinger K, . Natural history of progressive supranuclear palsy (steele-richardson-olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1996;60:615–20.
– reference: Nóbrega AC, Rodrigues B, Melo A. Is silent aspiration a risk factor for respiratory infection in Parkinson’s disease patients. Parkinsonism Relat Disord. 2008 Dec;14:646–8.
– reference: Thomsen TR, Galpern WR, Asante A, Arenovich T, Fox SH. Ipratropium bromide spray as treatment for sialorrhea in Parkinson’s disease. Mov Disord. 2007 Nov;22:2268–73.
– reference: Diederich NJ, Vaillant M, Leischen M, Mancuso G, Golinval S, Nati R, . Sleep apnea syndrome in Parkinson’s disease. A case-control study in 49 patients. Mov Disord. 2005;20:1413–8.
– reference: Arnulf I, Konofal E, Merino-Andreu M, Houeto JL, Mesnage V, Welter ML, . Parkinson’s disease and sleepiness: an integral part of PD. Neurology. 2002 Apr;58:1019–24.
– reference: Moraes W, Poyares D, Sukys-Claudino L, Guilleminault C, Tufik S. Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study. Chest. 2008;133:677–83.
– reference: Catalá-López F, Suárez-Pinilla M, Suárez-Pinilla P, Valderas JM, Gómez-Beneyto M, Martinez S, . Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies. Psychother Psychosom. 2014 Jan;83:89–105.
– reference: Kato B, Yamada K, Horiuchi M, Hirayama T, Hasegawa Y. [Case of Parkinson’s disease presenting with unique dyspneic attacks caused by oromandibular dystonia and sleep apnea syndrome]. Rinsho Shinkeigaku. 2007 Sep [cited 2020 Oct 6];47:577–80. Japanese.
– reference: Ghoroyeb I, Bioulac B, Tison F, Hirayama M, Sobue G, Fukatsu H, . Relationship between stridor and sleep apnoea syndrome: is it as simple as that? [11] (multiple letters). J Neurol Neurosurg Psychiatry. 2004 [cited 2020 Oct 6];75:512–3.
– ident: ref57
  doi: 10.1097/00002826-200603000-00005
– ident: ref38
  doi: 10.1016/j.parkreldis.2010.07.004
– ident: ref44
  doi: 10.1161/01.STR.0000226403.00963.af
– ident: ref26
  doi: 10.1016/0022-510x(96)00003-2
– ident: ref48
  doi: 10.1378/chest.07-1446
– ident: ref40
  doi: 10.1111/j.1469-7793.2001.t01-1-00237.x
– ident: ref28
  doi: 10.1056/NEJM198412063112314
– ident: ref63
  doi: 10.4049/jimmunol.1002449
– ident: ref46
  doi: 10.1016/s0025-7125(02)00007-x
– ident: ref45
  doi: 10.1111/j.1468-1331.2010.03340.x
– ident: ref49
  doi: 10.1136/jnnp.51.1.161
– ident: ref55
  doi: 10.1016/s1579-2129(07)60118-9
– ident: ref7
  doi: 10.1001/archinte.1982.00340210062015
– ident: ref21
  doi: 10.1212/WNL.0000000000000879
– ident: ref64
  doi: 10.1155/2014/103780
– ident: ref54
  doi: 10.1016/j.ejim.2004.09.014
– ident: ref15
  doi: 10.1001/jama.285.22.2888
– ident: ref18
  doi: 10.1159/000356498
– ident: ref51
  doi: 10.1002/mds.10072
– ident: ref62
  doi: 10.1097/JTO.0000000000000345
– ident: ref60
  doi: 10.1111/jgs.13054
– ident: ref1
  doi: 10.1111/j.1582-4934.2008.00296.x
– ident: ref35
  doi: 10.1371/journal.pone.0100828
– ident: ref14
  doi: 10.1016/j.mehy.2005.06.014
– ident: ref37
  doi: 10.1136/jnnp.60.6.615
– ident: ref29
  doi: 10.1002/mds.23139
– ident: ref31
  doi: 10.1017/s0317167100003991
– ident: ref52
  doi: 10.1159/000029224
– ident: ref13
  doi: 10.2174/1567205011310050011
– ident: ref59
  doi: 10.1001/archinternmed.2009.229
– ident: ref22
  doi: 10.1016/j.parkreldis.2007.12.007
– ident: ref24
  doi: 10.1513/AnnalsATS.201310-360OC
– ident: ref32
  doi: 10.1093/sleep/23.3.1c
– ident: ref36
  doi: 10.1158/1055-9965.EPI-07-0038
– ident: ref42
  doi: 10.1016/s0140-6736(00)02824-5
– ident: ref53
  doi: 10.2147/ndt.s2006
– ident: ref61
  doi: 10.1016/j.neurobiolaging.2011.09.038
– ident: ref50
  doi: 10.1055/s-2002-33034
– ident: ref58
  doi: 10.1001/jamainternmed.2014.7663
– ident: ref65
  doi: 10.1002/mds.21730
– ident: ref16
  doi: 10.3233/JAD-170445
– ident: ref8
  doi: 10.1016/j.rmed.2012.03.013
– ident: ref5
  doi: 10.1007/978-3-540-69248-5_6
– ident: ref4
  doi: 10.3390/ijerph7103760
– ident: ref10
  doi: 10.1164/ajrccm/148.2.418
– ident: ref9
  doi: 10.1378/chest.130.6.1687
– ident: ref23
  doi: 10.1007/s00455-009-9244-x
– ident: ref39
  doi: 10.1002/mds.21992
– ident: ref2
  doi: 10.1016/S1474-4422(11)70072-2
– ident: ref3
  doi: 10.1016/s0197-4580(02)00156-2
– ident: ref6
  doi: 10.1007/978-3-540-69248-5_5
– ident: ref27
  doi: 10.1016/s0003-9993(96)90216-6
– ident: ref43
  doi: 10.1016/j.jns.2006.03.008
– ident: ref56
  doi: 10.1001/archneur.62.8.1290
– ident: ref25
  doi: 10.1097/01.pas.0000213418.08009.f9
– ident: ref11
  doi: 10.1164/rccm.200902-0276OC
– ident: ref17
  doi: 10.1021/acschemneuro.8b00442
– ident: ref47
  doi: 10.1345/aph.1C036
– ident: ref41
  doi: 10.1007/s00702-005-0348-7
– ident: ref19
  doi: 10.7150/thno.21408
– ident: ref33
  doi: 10.1016/s0954-6111(03)00188-4
– ident: ref34
  doi: 10.1093/ageing/afj087
– ident: ref12
  doi: 10.1378/chest.11-3035
– ident: ref20
  doi: 10.1002/ana.10277
– ident: ref30
  doi: 10.1097/00005768-199906000-00001
SSID ssj0008330
Score 2.3013675
SecondaryResourceType review_article
Snippet Chronic respiratory disorders represent a world epidemic. Their incidence and prevalence in the world population is increasing, and especially among elderly...
SourceID pubmedcentral
proquest
pubmed
crossref
karger
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 501
SubjectTerms Aged
Aging
Alzheimer Disease
Alzheimer's disease
Asthma
Chronic obstructive pulmonary disease
Cognitive ability
Dysphagia
Dyspnea
Granulomas
Humans
Hypotheses
Lung cancer
Lung diseases
Neurodegeneration
Neurodegenerative Diseases
Ostomy
Parkinson Disease
Parkinson's disease
Pathology
Pneumonia
Respiratory diseases
Respiratory failure
Respiratory Tract Diseases
Review
Risk factors
Sleep disorders
Smoking
Swallowing
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED-6doy9lLXLWq9ZUcce-iIaW5I_-lJKuxAGGWGskDcjS3I3WpwsSf__nT7sLCHs1XfYRnc6_U53_A7gS85zxB1G04LxgnIpGJUs1rTOUiUTPKAS7bp8v6ejB_5tKqbhwm0Z2irbmOgCtZ4pe0d-lRTO_4pscDP_Q-3UKFtdDSM0XsGBpS6zyVc27RIuRBfMsxHEMc1EFgdmITzB3Sw7C63jjfPo9ZNtv17sQpvbTZP_nELDd3AY4CO59fY-gj3THMObcSiQvwcVyG7Jj3UJndz7IsySyEYTx8ahzaOjm7axjrQEnMtrcksmlu5_QRDKEoSGxNMZ4bsfiWcQRW_qwcPw68-7EQ1zFKhCfLaidZ4bhXlZJRimV7JSOpGaVWlcaaU0bkmGOYPkQlVcp6KqDS9kYRtQVGq01BX7APvNrDGnQIwUac6LgTHcYIg1eS4tx5uyxUJVJ0kEl-1qliqQjNtZF8-lSzZEUXYLH8HnTnXumTV2KfW8STqV9nl_6_l4MvGicq5rFLcGLMOeXJZrD4rgohPjbrIlEtmY2QvqCARkIsWgFcGJt3f3BcYZzzEkRpBteEKnYJm6NyXN71-OsdvNPRykH___W2fwNrEdM65Zpg_7q8WL-YSQZ1WdO7_-C5US_14
  priority: 102
  providerName: ProQuest
Title Chronic Respiratory Diseases and Neurodegenerative Disorders: A Primer for the Practicing Clinician
URI https://karger.com/doi/10.1159/000518261
https://www.ncbi.nlm.nih.gov/pubmed/34348307
https://www.proquest.com/docview/2900318970
https://www.proquest.com/docview/2558456793
https://pubmed.ncbi.nlm.nih.gov/PMC8740106
Volume 30
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LS8QwEB58IV7Et_WxRPHgJbBtkjb15hMRVhZR2FtJk1RFqeKu_99J0lZX9NpMG9qZTL7JTL8BOJJcIu6whuaM55QrwahisaFVlmqV4AaVGF_le5teP_CbkRg15x3uX5gXV__sqVE7bgHccH3rOYeEMc6ZxziKOYseUNr5XMlY4B2IY5qJLG44hKZuXYJFxhmXzLWO_bEJLYQ5_4KYvyslf2w9Vyuw3GBGchqUvAoztl6DxUGTFV8H3TDckrvvvDm5CJmXMVG1IZ6Cw9hHzzHtHBxpWTfHJ-SUDB3H_wdB_EoQD5LAYYTPfiSBNhRNaAMeri7vz69p0zyBagRlE1pJaTUGY6VgGFOpUptEGVamcWm0NrgOGQYKigtdcpOKsrI8V7mrOtGpNcqUbBPm6rfabgOxSqSS531ruUW_aqVUjthNuwyhrpIkguP2axa6YRZ3DS5eCx9hiLzodBDBYSf6Hug0_hLaCCrpRNrre7-uD4bDMFS8mwqHWwUWzUIcF0nu3Vae9SM46IZxCbm8iKrt2yfKCERhIkVPFcFW0Hc3Q2sxEWRTltAJOHru6ZH6-cnTdPtmh_1055-32YWlxNXH-NKYPZibfHzafQQ4k7IHs9ko68H82eXt8K7njwl63t6_AOlB91Y
linkProvider Karger AG
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9MwED6NDgEviB_byBhgEEi8WDSxnThICA22qWNrVU2btLfg2M5AoLS0nSb-Kf5GznaS0Wniba--kxP5zufPuct3AK8ll4g7rKE54znlSjCqWGxolaVaJXhAJcZX-Y7SwQn_cipOV-BP-y-MK6tsY6IP1Gai3Tfyd0nu_S_P-h-nv6jrGuWyq20LjeAWB_b3BV7Z5h_2d9C-b5Jkb_f484A2XQWoRrSyoJWUVuMtpRQMLxuq1CZRhpVpXBqtDTooQwStuNAlN6koK8tzlbtyDJ1ao0zJcN5bsMoZQoUerH7aHY2PutgvGQv8B3FMM5HFDZcRYgbfPc-B-XjpBLz9wxV8z67Dt1fLNP859_YewP0GsJLt4GEPYcXWj-DOsEnJPwbd0OuSo8ukPdkJaZ85UbUhnv_D2DNPcO2iK2kpP-fvyTYZuwYDM4LgmSAYJYFACec-I4GzFP13DU5uZI3XoVdPavsEiFUilTzvW8stBnUrpXKsctqlJ3WVJBG8bVez0A2tueuu8bPw1xuRF93CR_CqU50GLo_rlNaCSTqVdnzryvhwPA6iYmoqFLcGLJooMC8ufTaCl50Y969LyqjaTs5RRyAEFCmGyQg2gr27JzDOuMQgHEG25AmdguMGX5bU3795jnDfabGfbv7_tV7A3cHx8LA43B8dPIV7iavX8aU6W9BbzM7tMwRci_J54-UEvt70xvoL_6I_wA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3daxQxEB9qK8UXsbXqaqupKPgSepuP_RCkFM-j3xxi4d622SRbS2XvvLsi_mv-dU6S3a1Xim99TYbskplMfrMz-xuAd5nIEHdYQ3MuciqU5FTx2NAqTbRieEEx46t8T5P9M3E4kqMl-NP-C-PKKluf6B21GWv3jXyH5d7-8rS3UzVlEcP-YHfyk7oOUi7T2rbTCCZyZH__wvBt9umgj7p-z9jgy7fP-7TpMEA1Ipc5rbLMaoxYSskx8FClNkwZXiZxabQ2aKwc0bQSUpfCJLKsrMhV7kozdGKNMiXHdR_ACorFrntCOuqCPUQ2PDAhxDFNZRo3rEaIHnwfPQfr44W78OGVK_2e3oV0bxds_nMDDp7A4wa6kr1ga2uwZOt1WD1pkvNPQTdEu-TrTfqe9EMCaEZUbYhnAjH2wlNdOz9LWvLP2UeyR4au1cCUIIwmCEtJoFLCtS9IYC9FS96As3vZ4WewXI9r-wKIVTLJRN6zVlh07zbLlOOX0y5RqSvGIvjQ7mahG4Jz12fjR-EDHZkX3cZH8LYTnQRWj7uENoJKOpF2fPPW-MlwGKaKialwulVg0fiDWXFjvRFsd9N4kl16RtV2fI0yEsGgTNBhRvA86Lt7AhdcZOiOI0gXLKETcCzhizP15XfPFu57LvaSl_9_rTewisepOD44PXoFj5gr3PE1O5uwPJ9e2y1EXvPytTdxAuf3fab-AkCXQpA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chronic+Respiratory+Diseases+and+Neurodegenerative+Disorders%3A+A+Primer+for+the+Practicing+Clinician&rft.jtitle=Medical+principles+and+practice&rft.au=Falsetti%2C+Lorenzo&rft.au=Viticchi%2C+Giovanna&rft.au=Zaccone%2C+Vincenzo&rft.au=Tarquinio%2C+Nicola&rft.date=2021-12-01&rft.issn=1011-7571&rft.eissn=1423-0151&rft.volume=30&rft.issue=6&rft.spage=501&rft.epage=507&rft_id=info:doi/10.1159%2F000518261&rft.externalDBID=n%2Fa&rft.externalDocID=10_1159_000518261
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1011-7571&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1011-7571&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1011-7571&client=summon